Brand Recall Hub

Impurity Recalls in Canada

46 recalls found for Impurity. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

46 Impurity Recalls

Health Products Type III
2026-01-12

Locametz powder for solution, kit; Out of specification (unknown impurity)

Product quality

View recall details →

Health Products Type II
2026-01-05

JAMP-ASA 81 mg EC; Out of specification (salicylic acid impurity)

Product quality

View recall details →

Health Products Type II
2025-09-08

Kids by Babyganics SPF 50 Mineral Sunscreen Totally Tropical (rollerball and continuous spray formulas): Impurity

Product quality

View recall details →

Health Products Type III
2025-06-06

Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity)

Product quality

View recall details →

Health Products Type III
2025-03-26

Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity)

Product quality

View recall details →

Health Products Type II
2025-03-21

Sandoz Fesoterodine Fumarate 8 mg tablet; Out of specification (Diester impurity)

Product quality

View recall details →

Health Products Type II
2024-12-09

SANDOZ FESOTERODINE FUMARATE: The Diester impurity is out of specification in the affected lot(s)

Product safety

View recall details →

Health Products Type II
2024-09-27

Mint-Risperidon tablet: Out of specification (Impurity)

Product quality

View recall details →

Health Products Type I
2024-08-05

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality - Labelling

View recall details →

Other
2024-08-03

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality

View recall details →

Health Products Type II
2024-05-16

Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)

Product quality

View recall details →

Health Products Type III
2023-12-08

Taro-Dipyridamole/ASA: impurity

Product quality

View recall details →

Health Products Type III
2023-10-23

Perichlor Without Alcohol: Result near the stability limit for an impurity.

Product quality

View recall details →

Health Products Type I
2023-08-16

AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity

Contamination

View recall details →

Health Products Type I
2023-08-16

PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity

Contamination

View recall details →

Health Products Type I
2023-08-14

Apo-Acyclovir Tablets: NDMA impurity (Updated with new product and lot numbers)

Contamination

View recall details →

Health Products Type I
2023-08-14

APO-AMITRIPTYLINE Tablets: NNORT impurity

Contamination

View recall details →

Health Products Type I
2023-08-14

Elavil 25 mg: NNORT Impurity

Contamination

View recall details →

Health Products Type II
2023-08-09

PMS-Montelukast: An impurity is out of trend

Product quality

View recall details →

Other
2023-02-07

Amitriptyline antidepressant drugs recalled because of a nitrosamine impurity

Contamination - Product safety

View recall details →

Health Products Type I
2023-02-07

APO-AMITRIPTYLINE 10mg: NDMA Impurity

Contamination - Product safety

View recall details →

Health Products Type II
2022-08-15

Zero Tolerance Plus Sanitizer: Contains undeclared impurity at elevated levels.

Product quality - COVID

View recall details →

Other
2022-07-28

Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity

Contamination

View recall details →

Health Products Type II
2022-06-02

Impurity - Pro Doc MONTELUKAST SODIUM 5mg

Product quality

View recall details →

Health Products Type II
2022-05-19

PMS-Montelukast: impurity

Product quality

View recall details →

Other
2022-04-21

Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity

Contamination

View recall details →

Health Products Type I
2022-04-20

Accupril Tabs: Nitrosamine impurity

Contamination

View recall details →

Other
2022-03-11

Ranitidine products recalled because of a nitrosamine impurity

Product safety

View recall details →

Health Products Type I
2022-03-11

Maximum Strength Acid Reducer Without prescription: NDMA impurity

Product quality

View recall details →

Health Products Type I
2022-03-04

Accuretic (quinapril hydrochloride and hydrochlorothiazide): Nitrosamine Impurity

Contamination

View recall details →

Showing 30 of 46 recalls. View all →